Tumor Stroma Interaction

A special issue of Cells (ISSN 2073-4409).

Deadline for manuscript submissions: 20 November 2025 | Viewed by 676

Special Issue Editor


E-Mail Website
Guest Editor
Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
Interests: innate immunity; NK cells; cytokines; immunomodulation; oncology; hematology; biochemistry; tumor markers; molecular markers; polymorphisms
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The relationship between cancer cells and the immune system represents a very complex interaction that is not fully understood. It is known that the cells in the tumor environment are suppressed so that they cannot perform an adequate induction of tumor cell apoptosis and so that the immune response is avoided by the tumor. For many years, the research focus was on general immunotherapy and immunostimulation. However, today we are working toward a better understanding of the phenomenon of immunosuppression of the immune system. Drugs that block the key points of immunosuppression do exist; however, despite research into the role of individual molecules and the creation of new drugs that block certain key molecules, as are in use today, resistance and insufficient tumor elimination remain. That is why research is necessary, and we require a better and more comprehensive understanding of these complex interactions in order to apply a new possibility of immune modulation based on new potential molecules. The aim of this Special Issue is to focus on better explaning mediators, cellular signals, individual cell subsets, and their surface markers, which participate in the complex interaction of a tumor and the immune system. At the same time, there is a need for a better understanding of immunomodulation and, finally, for an examination of the possibility of applying new and obtained findings in clinical work. Based on newly obtained research data, there remains hope that tumor treatment will be improved in the near future, based on individual therapy created for each individual and based on individual changes in each individual subject.

Prof. Dr. Vladimir Jurisic
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cells
  • cancer
  • inflammation
  • exocytosis
  • immune system
  • tumor stroma

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

31 pages, 1123 KB  
Review
The Role of Tumor Microenvironment in Triple-Negative Breast Cancer and Its Therapeutic Targeting
by Ana Vuletic, Katarina Mirjacic Martinovic and Vladimir Jurisic
Cells 2025, 14(17), 1353; https://doi.org/10.3390/cells14171353 - 30 Aug 2025
Viewed by 230
Abstract
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by rapid proliferation and infiltration of immune cells into tumor microenvironment (TME). The treatment of TNBC still remains challenging due to the lack of expression of effective molecular targets pertaining to [...] Read more.
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by rapid proliferation and infiltration of immune cells into tumor microenvironment (TME). The treatment of TNBC still remains challenging due to the lack of expression of effective molecular targets pertaining to the tumor cell itself. In TNBC standard of care, therapies such as chemotherapy, together with recently introduced immunotherapy with checkpoint inhibitors, often do not result in durable clinical response. Therefore, better understanding of complex interactions between tumor cells, immune cells, and stromal cells mediated by multiple cytokines, chemokines, enzymes, and metabolites in TME is crucial for understanding the mechanisms that underlie tumor cell immune evasion strategies. The aim of this review is to give comprehensive overview of immune cell network and their interactions with cells in TME and possibilities for therapeutic targeting of TME in TNBC. We discuss cancer-associated fibroblasts (CAFs) as an important recently characterized player in TNBC with respect to their role in interactions with immune cells and their impact on tumor invasion. Based on the recently accumulated knowledge, therapies targeting immune suppressive mechanisms and CAF-related tumor-promoting mechanisms in TME hold great potential for clinical evaluation in TNBC. Full article
(This article belongs to the Special Issue Tumor Stroma Interaction)
Show Figures

Figure 1

Back to TopTop